A recent JAMA-published study on U.S. hospitals’ financial performance during the COVID-19 public health emergency suffers from several methodological setbacks that undermine its credibility, writes Aaron Wesolowski, AHA’s vice president of policy, research, analytics and strategy. “Incomplete analyses like this are not reflective of the many immense struggles and challenges the hospital field has faced and continues to face, including a workforce shortage crisis, along with skyrocketing input costs for supplies, equipment, drugs and labor, and persistent inflation,” he concludes. “It is in everyone’s interest to keep hospitals strong and our patients healthy.” READ MORE

Related News Articles

Headline
The Centers for Disease Control and Prevention Dec. 11 released a report that found last year’s version of the COVID-19 vaccine was 76% effective in preventing…
Headline
The AHA provided recommendations to the Food and Drug Administration Dec. 1 in response to a request for information on the measurement and evaluation of…
Headline
The Food and Drug Administration has identified a Class I recall of Baxter Life2000 Ventilation Systems due to a cybersecurity issue discovered through…
Headline
Flu cases are growing or likely growing in 39 states, according to the latest Centers for Disease Control and Prevention data from Nov. 11. COVID-19…
Headline
A blog by Ariel Levin, AHA director of coverage policy and state issues, highlights considerations for hospital finance and revenue cycle leaders in the face…
Headline
In the final episode of a four-part series with the Association for Healthcare Philanthropy, CommonSpirit Health’s Daniel Morissette, senior executive vice…